Inhibition of the Human Proteasome by Imidazoline Scaffolds-Reference-Cited by-同舟云学术

Inhibition of the Human Proteasome by Imidazoline Scaffolds

Published:2013-07-03 Issue:14 Volume:56 Page:5974-5978
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Azevedo Lauren M.¹,Lansdell Theresa A.¹,Ludwig Jacob R.¹,Mosey Robert A.¹,Woloch Daljinder K.¹,Cogan Dillon P.¹,Patten Gregory P.¹,Kuszpit Michael R.¹,Fisk Jason S.¹,Tepe Jetze J.¹

Affiliation:

1. Department of Chemistry, Michigan State University, East Lansing, Michigan 48824, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm400235r

Reference32 articles.

1. Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

2. Proteasome Inhibitors: An Expanding Army Attacking a Unique Target

3. Joining the Army of Proteasome Inhibitors

4. 20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development

5. Proteasome inhibitors in the treatment of multiple myeloma

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological impacts of imidazoline derivatives;Chemical Papers;2024-05-15

2. Reactions of Oxazol-5(4H)-ones Involving Organosilicone Reagents (A Review);Russian Journal of Organic Chemistry;2024-05

3. TCH-165 attenuates cardiac ischaemia/reperfusion injury by balancing mitochondrial dynamics via increasing proteasome activity;European Journal of Pharmacology;2023-10

4. Synthesis and antiplatelet activity of 2-substituted imidazolines;Russian Chemical Bulletin;2023-07

5. Recent advances and future perspectives of noncompetitive proteasome inhibitors;Bioorganic Chemistry;2023-06